Bipolar spectrum disorders: New perspectives

Canadian Family Physician

Volumn 48, Issue MAY, 2002, Pages 896-904

  Piver, Andre ^a,d   Yatham, Lakshmi N ^b   Lam, Raymond W ^b,c  

^a Nelson Mental Health Centre   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Nelson Mental Health Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLONAZEPAM; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRANYLCYPROMINE; VALPROIC ACID; VENLAFAXINE;

ANXIETY NEUROSIS; ARTICLE; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DEPRESSION; ELECTROCONVULSIVE THERAPY; GENERAL PRACTITIONER; HUMAN; HYPOMANIA; INTERVIEW; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; MENTAL HEALTH CARE; MOOD; PHOTOTHERAPY; PREVALENCE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SLEEP DEPRIVATION; SYMPTOM;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FAMILY PRACTICE; HUMANS; PREVALENCE; QUESTIONNAIRES;

EID: 0036089684     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. The bipolar spectrum: A clinical reality in search of diagnostic criteria and an assessment methodology
2. Systematic clinical methodology for validating bipolar-II disorder: Data in mid-stream from a French national multi-site study (EPIDEP)
3. The evolving bipolar spectrum. Prototypes I, II, III, and IV
4. Proposed subtypes of bipolar II and related disorders: With hypomanic episodes (or cyclothymia) and with hyperthymic temperament
5. The role of bipolarity in depression in the family practice setting
6. The emerging epidemiology of hypomania and bipolar II disorder
7. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients
8. Rapid-cycling bipolar disorder. An overview of research and clinical experience
9. Practice guidelines for the treatment of patients with bipolar disorder
10. The treatment of bipolar disorder: Review of the literature, guidelines, and options
11. The Expert Consensus Guidelines Series: Medication treatment of bipolar disorder 2000
12. Personality disorders in bipolar II patients
13. The validity of atypical depression in DSM-IV
14. Expanding the group of bipolar disorders
15. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course
16. Can antidepressant induce rapid cycling?
17. Cade's disease and beyond: Misdiagnosis, antidepressant use and proposed definition for bipolar spectrum disorder
18. On the nature of depressive and anxious states in a family practice setting: The high prevalence of bipolar II and related disorders in a cohort followed longitudinally
19. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire
20. Cross-national epidemiology of major depression and bipolar disorder
21. Major depression in 1998: Are we providing optimal therapy?
22. Prevalence of bipolar II disorder in atypical depression
23. The high prevalence of "soft" bipolar (II) features in atypical depression
24. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?
25. Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice
26. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder
27. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: Is there a bipolar II connection?
28. Bipolar II disorder and comorbidity
29. Health care utilization and costs among patients treated for bipolar disorder in an insured population
30. Bipolar depression: Treatment options
31. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs
32. Expert Consensus Guidelines for treating depression in bipolar disorder
33. Continuation and prophylactic treatment of bipolar disorder
34. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders
35. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified
36. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression
37. Low-dose valproate: A new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome
38. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode
39. Fluoxetine treatment of bipolar II depression
40. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode
41. Long-term preventive care in depression: The use of bupropion in patients intolerant of other antidepressants
42. Tranylcypromine versus imipramine in anergic bipolar depression
43. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder
44. Gabapentin treatment of mood disorders: A preliminary study
45. Gabapentin treatment of the non-refractory bipolar spectrum: An open case series
46. Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial
47. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
48. Acute treatment of bipolar depression with gabapentin
49. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder
50. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder
51. Treatment with atypical antipsychotics: New indications and new populations
52. Use of clonazepam for bipolar affective disorder
53. Somatic treatments for bipolar disorder
54. Clinical guidelines for the treatment of depressive disorders. III. Psychotherapy
55. Effectiveness of psychosocial treatments in bipolar disorder: State of the evidence
56. Psychosocial interventions as an adjunct to pharmacotherapy in bipolar disorder
57. Interpersonal and social rhythm therapy: Managing the chaos of bipolar disorder
58. Bipolar depression: Pharmacotherapy and related therapeutic strategies
59. Treatment of bipolar depression
60. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?
61. Bipolar rapid cycling: Focus on depression as its hallmark
62. Treatment of mania, mixed state, and rapid cycling
63. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments
64. Family physicians and the mental health system. Report from the Mental Health Supplement to the Ontario Health Survey